Evidence map›Paper›PMID 32737069›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2021

Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients.

Chia Siang Kow, Toby Capstick, Syed Tabish Razi Zaidi, Syed Shahzad Hasan

Abstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chia Siang KowSchool of Postgraduate Studies, International Medical University, Kuala Lumpur, Wilayah Persekutuan, Malaysia.
Toby CapstickDepartment of Pharmacy, Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK.
Syed Tabish Razi ZaidiSchool of Healthcare, University of Leeds, Leeds, West Yorkshire, UK.
Syed Shahzad HasanDepartment of Pharmacy, University of Huddersfield, Huddersfield, West Yorkshire, UK shahzad_pharmacy@yahoo.com.ORCID 0000-0002-4058-2215

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA significant knowledge gap exists for the management of critically ill patients with coronavirus disease 2019 (COVID-19). This study aimed to systematically investigate the consistency of recommendations from the available clinical practice guidelines (CPGs) to those of the WHO on the management of critically ill COVID-19 patients.

methodsWe examined CPGs and UpToDate point-of-care resources on the management of critically ill COVID-19 patients that had been published as of 30 April 2020 and compared them against the CPG by the WHO. The main outcome was the rate of consistency among CPGs for the management of critically ill COVID-19 patients. Sensitivity analyses were conducted by excluding recommendation statements that were described as insufficient evidence and by excluding single CPGs one at a time.

resultsThirteen reference recommendations derived from the CPG of the WHO were generated using discrete and unambiguous specifications of the population, intervention, and comparison states. Across CPGs, the rate of consistency in direction with the WHO is 7.7%. When insufficient evidence codings were excluded, the rate of consistency increased substantially to 61.5%. The results of a leave-one-out sensitivity analysis suggested that the UpToDate recommendation source could explain the inconsistency. Consistency in direction rates changed by an absolute 23.1% (from 1/13 (7.7%) to 4/13 (30.8%)) if UpToDate was removed.

conclusionsWe observed inconsistencies between some recommendations of the CPGs and those of the WHO. These inconsistencies should best be addressed by consensus among the relevant bodies to avoid confusion in clinical practice while awaiting clinical trials to inform us of the best practice.

Indexed as

ConsensusCOVID-19Critical CareCritical IllnessCross-Sectional StudiesHumansMedication Therapy ManagementPractice Guidelines as TopicSurveys and QuestionnairesWorld Health Organizationclinical auditclinical governanceclinical pharmacyinfectious diseasesintensive & critical care

Identifiers

PMID32737069
PMCPMC7788212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.